<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037775</url>
  </required_header>
  <id_info>
    <org_study_id>EPAPHemo</org_study_id>
    <nct_id>NCT03037775</nct_id>
  </id_info>
  <brief_title>The Influence of Electronic and Traditional Cigarettes Smoking on Hemodynamic Parameters</brief_title>
  <acronym>EPAPHemo</acronym>
  <official_title>The Influence of Electronic and Traditional Cigarettes Smoking on Hemodynamic Parameters and Sympathetic Nerves Activity in Healthy People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is intended to examine 50 healthy volunteers aged 18 - 60 years. 12-hour abstinence from
      tobacco smoke, alcohol or coffee before the experiment will be required. The exclusion
      criteria are medical history of stroke, coronary artery disease, chronic heart failure,
      hypertension, peripheral vascular disease, atrial fibrillation, polyneuropathy, obesity (BMI&gt;
      30 kg/m2), the current active disease (eg. viral infection). Test subjects will actively
      inhale for 10 minutes tobacco or the e-cigarette smoke with nicotine fluid (18 mg/ml) or
      fluid without nicotine for 10 minutes. The study protocol involves random allocation to
      groups exposed to electronic or traditional cigarette smoke in cross-over scheme. The primary
      endpoint is the maximum change in heart rate compared to mean values prior to exposure.
      Secondary end points is the maximum change in the measured parameters (hemodynamic and
      autonomic values) compared to the average values before exposure. The measurements will be
      performed using the Task Force Monitor system for non-invasive measurement of hemodynamic
      parameters and the assessment of autonomic function. Adrenergic activity will be tested with
      microneurography. A periodic analysis is planned after examining 15 and 35 patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>RR intervals in ms, very low frequency (VLF), low frequency (LF), and high frequency (HF) components - ms2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic, diastolic, mean blood pressure</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>mm Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>beats/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure variability</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>mm Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Puls wave velocity</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>m/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Volume</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>ml/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Peripheral Resistance</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>dyn*sec/cm5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baroreceptor reflex sensitivity</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>ms/mm Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle sympathetic nerve activity</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>bursts/min, bursts/100 beats/min</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tobacco; Use, Harmful</condition>
  <arm_group>
    <arm_group_label>Investigated group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects underwent procedures: hemodynamic indices will be measured at baseline and during 1/ e-cigarette without nicotine smoking, 2/ e-cigarette with nicotine and during 3/ traditional cigarette smoking in random order</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baseline</intervention_name>
    <description>measurement of baseline hemodynamic parameters</description>
    <arm_group_label>Investigated group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>e-cigarette without nicotine</intervention_name>
    <description>measurement hemodynamic parameters during smoking e-cigarette without nicotine</description>
    <arm_group_label>Investigated group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>e-cigarette with nicotine</intervention_name>
    <description>measurement hemodynamic parameters smoking e-cigarette with nicotine</description>
    <arm_group_label>Investigated group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>traditional cigarette</intervention_name>
    <description>measurement hemodynamic parameters smoking traditional cigarette</description>
    <arm_group_label>Investigated group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers aged 18 - 60 years

          -  12-hour abstinence from tobacco smoke, alcohol or coffee before the experiment will be
             required

        Exclusion Criteria:

          -  history of stroke, coronary artery disease, chronic heart failure, hypertension,
             peripheral vascular disease, atrial fibrillation, polyneuropathy, obesity (BMI&gt; 30
             kg/m2), the current active disease (eg. viral infection).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacek Lewandowski, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paweł Dziliński, M.D.</last_name>
    <phone>48 22 599 2828</phone>
    <email>pawel.dzilinski@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jacek Lewandowski, M.D., Ph.D.</last_name>
    <phone>48 22 599 2828</phone>
    <email>jlewandowski@wum.edu.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Warszawski Uniwersytet Medyczny</name>
      <address>
        <city>Warszawa</city>
        <state>Mazowieckie</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Lewandowski, M.D., Ph.D.</last_name>
      <phone>22 599 2828</phone>
      <phone_ext>+48</phone_ext>
      <email>jlewandowski@wum.edu.pl</email>
    </contact>
    <contact_backup>
      <last_name>Paweł Dziliński, M.D.</last_name>
      <phone>22 599 2828</phone>
      <phone_ext>+48</phone_ext>
      <email>pawel.dzilinski@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2017</study_first_submitted>
  <study_first_submitted_qc>January 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2017</study_first_posted>
  <last_update_submitted>January 27, 2017</last_update_submitted>
  <last_update_submitted_qc>January 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Jacek Lewandowski</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>tobacco</keyword>
  <keyword>cardiovascular system</keyword>
  <keyword>sympathetic nervous system</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

